Jump to content

BOL-148 n the news


Recommended Posts

Halpern crows about BOL-148 in an article by the Bloomberg news service.

Already, LSD and psilocybin research by psychiatrist John Halpern at Harvard has led to a drug, dubbed BOL-148, being developed by Boston-based startup Entheogen Corp.

The company is studying BOL-148, an LSD derivative, as a treatment for cluster headaches, sometimes called suicide headaches because theyÂ’re so painful that sufferers often kill themselves, said Halpern, EntheogenÂ’s co-founder.


Link to comment
Share on other sites

Ooh good catch Tommy D, thanks.

That article certainly is a good thing to have out there in the mainstream media IMO, and I see it also touches on the positive after effect a psychedelic mushroom experience can have on a person's outlook, as some of us have personally reported here.  [smiley=thumbup.gif]

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...